The Use of Galantamine and CDP-Choline to Treat Adults With Schizophrenia (STAR-1)

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Schizophrenia
2		More general conditions related to this trial
			Mental Disorders
			Schizophrenia and Disorders with Psychotic Features
3		Interventions listed in this trial
			Galantamine
			CDP-choline
			Placebo
			Risperidone
4		Additional drug interventions recognized in this trial
			Choline
			Cytidine Diphosphate Choline
5		More general drug interventions related to this trial
			Antilipemic Agents
			Antimetabolites
			Antipsychotic Agents
			Autonomic Agents
			Central Nervous System Agents
			Central Nervous System Depressants
			Cholinergic Agents
			Cholinesterase Inhibitors
			Dopamine Agents
			Dopamine Antagonists
			Enzyme Inhibitors
			Gastrointestinal Agents
			Lipotropic Agents
			Molecular Mechanisms of Pharmacological Action
			Neurotransmitter Agents
			Nootropic Agents
			Parasympathomimetics
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Psychotropic Drugs
			Serotonin Agents
			Serotonin Antagonists
			Therapeutic Uses
			Tranquilizing Agents
6		Sponsors listed in this trial
			National Institute of Mental Health (NIMH)